Growth Hormone Administration: Is It Safe and Effective for Athletic Performance

Endocrinology and Metabolism Clinics of North America

Volumn 39, Issue 1, 2010, Pages 11-23

  Birzniece, Vita ^a   Nelson, Anne E ^a   Ho, Ken K Y ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Anaerobic exercise capacity; Athletes; Growth hormone; Muscle strength; Physical performance; Side effects

Indexed keywords

ANABOLIC AGENT; GROWTH HORMONE; PLACEBO; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; TESTOSTERONE;

ACROMEGALY; AEROBIC CAPACITY; ANAEROBIC CAPACITY; ARTHRALGIA; ATHLETE; ATHLETIC PERFORMANCE; BODY COMPOSITION; CLINICAL TRIAL; DOPING; ENDURANCE; EXERCISE TOLERANCE; FLUID RETENTION; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; LEAN BODY WEIGHT; MORTALITY; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE TRAINING; NEOPLASM; NONHUMAN; PHYSICAL PERFORMANCE; PLACEBO EFFECT; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW; TISSUE REPAIR;

ADULT; AEROBIOSIS; ANAEROBIOSIS; ATHLETIC PERFORMANCE; BODY COMPOSITION; DOPING IN SPORTS; EXERCISE; HUMAN GROWTH HORMONE; HUMANS; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PROTEINS; RISK FACTORS;

EID: 74049141388     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2009.10.007     Document Type: Review

References (75)

1. Holt R.I., and Sonksen P.H. Growth hormone, IGF-I and insulin and their abuse in sport. Br J Pharmacol 154 (2008) 542
2. Holt R.I., Erotokritou-Mulligan I., and Sonksen P.H. The history of doping and growth hormone abuse in sport. Growth Horm IGF Res 19 4 (2009) 320-326
3. Saugy M., Robinson N., Saudan C., et al. Human growth hormone doping in sport. Br J Sports Med 40 Suppl 1 (2006) i35
4. Ezzat S., Forster M.J., Berchtold P., et al. Acromegaly. Clinical and biochemical features in 500 patients. Medicine (Baltimore) 73 (1994) 233
5. Fazio S., Cittadini A., Biondi B., et al. Cardiovascular effects of short-term growth hormone hypersecretion. J Clin Endocrinol Metab 85 (2000) 179
6. Ehrnborg C., Lange K.H., Dall R., et al. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J Clin Endocrinol Metab 88 (2003) 394
7. Giannoulis M.G., Boroujerdi M.A., Powrie J., et al. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults. Clin Endocrinol (Oxf) 62 (2005) 315
8. Wallace J.D., Cuneo R.C., Baxter R., et al. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. J Clin Endocrinol Metab 84 (1999) 3591
9. Wallace J.D., Cuneo R.C., Bidlingmaier M., et al. The response of molecular isoforms of growth hormone to acute exercise in trained adult males. J Clin Endocrinol Metab 86 (2001) 200
10. Carroll P.V., Christ E.R., Bengtsson B.A., et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83 (1998) 382
11. Gibney J., Healy M.L., and Sonksen P.H. The growth hormone/insulin-like growth factor-I axis in exercise and sport. Endocr Rev 28 (2007) 603
12. Gibney J., Wallace J.D., Spinks T., et al. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. J Clin Endocrinol Metab 84 (1999) 2596
13. Rodriguez-Arnao J., Jabbar A., Fulcher K., et al. Effects of growth hormone replacement on physical performance and body composition in GH deficient adults. Clin Endocrinol (Oxf) 51 (1999) 53
14. Attanasio A.F., Bates P.C., Ho K.K., et al. Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status-3-year results from the HypoCCS Database. J Clin Endocrinol Metab 87 (2002) 1600
15. Burt M.G., Gibney J., Hoffman D.M., et al. Relationship between GH-induced metabolic changes and changes in body composition: a dose and time course study in GH-deficient adults. Growth Horm IGF Res 18 (2008) 55
16. Gotherstrom G., Svensson J., Koranyi J., et al. A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. J Clin Endocrinol Metab 86 (2001) 4657
17. Wolthers T., Hoffman D.M., Nugent A.G., et al. Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. Am J Physiol Endocrinol Metab 281 (2001) E1191
18. Woodhouse L.J., Mukherjee A., Shalet S.M., et al. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr Rev 27 (2006) 287
19. Sartorio A., and Narici M.V. Growth hormone (GH) treatment in GH-deficient adults: effects on muscle size, strength and neural activation. Clin Physiol 14 (1994) 527
20. Cuneo R.C., Salomon F., Wiles C.M., et al. Skeletal muscle performance in adults with growth hormone deficiency. Horm Res 33 Suppl 4 (1990) 55
21. Cuneo R.C., Salomon F., Wiles C.M., et al. Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength. J Appl Physiol 70 (1991) 688
22. Woodhouse L.J., Asa S.L., Thomas S.G., et al. Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 84 (1999) 4570
23. Widdowson M.W., and Gibney J. The effect of growth hormone (GH) replacement on muscle strength in patients with GH-deficiency: a meta-analysis. Clin Endocrinol (Oxf) (2009) in press
24. Jorgensen J.O., Pedersen S.A., Thuesen L., et al. Long-term growth hormone treatment in growth hormone deficient adults. Acta Endocrinol (Copenh) 125 (1991) 449
25. Jorgensen J.O., Thuesen L., Muller J., et al. Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. Eur J Endocrinol 130 (1994) 224
26. Svensson J., Sunnerhagen K.S., and Johannsson G. Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength. J Clin Endocrinol Metab 88 (2003) 2061
27. Cuneo R.C., Salomon F., Wiles C.M., et al. Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appl Physiol 70 (1991) 695
28. Cenci M.C., Soares D.V., Spina L.D., et al. Effects of 5 years of growth hormone (GH) replacement therapy on cardiac parameters and physical performance in adults with GH deficiency. Pituitary 12 4 (2009) 322-329
29. Nass R., Huber R.M., Klauss V., et al. Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Metab 80 (1995) 552
30. Widdowson W.M., and Gibney J. The effect of growth hormone replacement on exercise capacity in patients with GH deficiency: a metaanalysis. J Clin Endocrinol Metab 93 (2008) 4413
31. Merola B., Longobardi S., Sofia M., et al. Lung volumes and respiratory muscle strength in adult patients with childhood- or adult-onset growth hormone deficiency: effect of 12 months' growth hormone replacement therapy. Eur J Endocrinol 135 (1996) 553
32. Colao A., Di Somma C., Cuocolo A., et al. The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study. J Clin Endocrinol Metab 89 (2004) 5998
33. El-Sayed M.S., Ali N., and El-Sayed Ali Z. Haemorheology in exercise and training. Sports Med 35 (2005) 649
34. Moller J., Frandsen E., Fisker S., et al. Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study. Clin Endocrinol (Oxf) 44 (1996) 533
35. Yarasheski K.E., Campbell J.A., Smith K., et al. Effect of growth hormone and resistance exercise on muscle growth in young men. Am J Physiol 262 (1992) E261
36. Healy M.L., Gibney J., Russell-Jones D.L., et al. High dose growth hormone exerts an anabolic effect at rest and during exercise in endurance-trained athletes. J Clin Endocrinol Metab 88 (2003) 5221
37. Chesley A., MacDougall J.D., Tarnopolsky M.A., et al. Changes in human muscle protein synthesis after resistance exercise. J Appl Physiol 73 (1992) 1383
38. Yarasheski K.E., Zachweija J.J., Angelopoulos T.J., et al. Short-term growth hormone treatment does not increase muscle protein synthesis in experienced weight lifters. J Appl Physiol 74 (1993) 3073
39. Miller M.E., Cosgriff J.M., and Forbes G.B. Bromide space determination using anion-exchange chromatography for measurement of bromide. Am J Clin Nutr 50 (1989) 168
40. Liu H., Bravata D.M., Olkin I., et al. Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med 148 (2008) 747
41. Moller J., Jorgensen J.O., Moller N., et al. Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man. J Clin Endocrinol Metab 72 (1991) 768
42. Ehrnborg C., Ellegard L., Bosaeus I., et al. Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults. Clin Endocrinol (Oxf) 62 (2005) 449
43. Meinhardt U, Nelson AE, Hansen JL, et al. The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized placebo-controlled trial. Ann Intern Med, in press.
44. Deyssig R., Frisch H., Blum W.F., et al. Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes. Acta Endocrinol (Copenh) 128 (1993) 313
45. Lange K.H., Larsson B., Flyvbjerg A., et al. Acute growth hormone administration causes exaggerated increases in plasma lactate and glycerol during moderate to high intensity bicycling in trained young men. J Clin Endocrinol Metab 87 (2002) 4966
46. Irving B.A., Patrie J.T., Anderson S.M., et al. The effects of time following acute growth hormone administration on metabolic and power output measures during acute exercise. J Clin Endocrinol Metab 89 (2004) 4298
47. Berggren A., Ehrnborg C., Rosen T., et al. Short-term administration of supraphysiological recombinant human growth hormone (GH) does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-insulin-like growth factor I axes. J Clin Endocrinol Metab 90 (2005) 3268
48. Graham M.R., Baker J.S., Evans P., et al. Physical effects of short-term recombinant human growth hormone administration in abstinent steroid dependency. Horm Res 69 (2008) 343
49. Brumback R.A., and Barr C.E. Myopathy in acromegaly. A case study. Pathol Res Pract 177 (1983) 41
50. Nagulesparen M., Trickey R., Davies M.J., et al. Muscle changes in acromegaly. Br Med J 2 (1976) 914
51. Thomas S.G., Woodhouse L.J., Pagura S.M., et al. Ventilation threshold as a measure of impaired physical performance in adults with growth hormone excess. Clin Endocrinol (Oxf) 56 (2002) 351
52. Price D.D., Finniss D.G., and Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 59 (2008) 565
53. Pollo A., Carlino E., and Benedetti F. The top-down influence of ergogenic placebos on muscle work and fatigue. Eur J Neurosci 28 (2008) 379
54. Beedie C.J., and Foad A.J. The placebo effect in sports performance: a brief review. Sports Med 39 (2009) 313
55. Benedetti F., Pollo A., and Colloca L. Opioid-mediated placebo responses boost pain endurance and physical performance: is it doping in sport competitions?. J Neurosci 27 (2007) 11934
56. Longobardi S., Keay N., Ehrnborg C., et al. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J Clin Endocrinol Metab 85 (2000) 1505
57. Nelson A.E., Meinhardt U., Hansen J.L., et al. Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes. J Clin Endocrinol Metab 93 (2008) 2213
58. Kurtz C.A., Loebig T.G., Anderson D.D., et al. Insulin-like growth factor I accelerates functional recovery from Achilles tendon injury in a rat model. Am J Sports Med 27 (1999) 363
59. Cittadini A., Berggren A., Longobardi S., et al. Supraphysiological doses of GH induce rapid changes in cardiac morphology and function. J Clin Endocrinol Metab 87 (2002) 1654
60. Keller A., Wu Z., Kratzsch J., et al. Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration. Eur J Endocrinol 156 (2007) 647
61. Young J., and Anwar A. Strong diabetes. Br J Sports Med 41 (2007) 335
62. Johannsson G., Gibney J., Wolthers T., et al. Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men. J Clin Endocrinol Metab 90 (2005) 3989
63. Karila T.A., Karjalainen J.E., Mantysaari M.J., et al. Anabolic androgenic steroids produce dose-dependant increase in left ventricular mass in power athletes, and this effect is potentiated by concomitant use of growth hormone. Int J Sports Med 24 (2003) 337
64. Mark P.B., Watkins S., and Dargie H.J. Cardiomyopathy induced by performance enhancing drugs in a competitive bodybuilder. Heart 91 (2005) 888
65. Meyers D.E., and Cuneo R.C. Controversies regarding the effects of growth hormone on the heart. Mayo Clin Proc 78 (2003) 1521
66. Colao A., Baldelli R., Marzullo P., et al. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endocrinol Metab 85 (2000) 193
67. Ayuk J., and Sheppard M.C. Does acromegaly enhance mortality?. Rev Endocr Metab Disord 9 (2008) 33
68. Bratusch-Marrain P.R., Smith D., and DeFronzo R.A. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55 (1982) 973
69. Fowelin J., Attvall S., von Schenck H., et al. Characterization of the insulin-antagonistic effect of growth hormone in man. Diabetologia 34 (1991) 500
70. Rizza R.A., Mandarino L.J., and Gerich J.E. Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31 (1982) 663
71. Perry J.K., Emerald B.S., Mertani H.C., et al. The oncogenic potential of growth hormone. Growth Horm IGF Res 16 (2006) 277
72. Orme S.M., McNally R.J., Cartwright R.A., et al. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83 (1998) 2730
73. Colao A., Pivonello R., Scarpa R., et al. The acromegalic arthropathy. J Endocrinol Invest 28 (2005) 24
74. Wassenaar M.J., Biermasz N.R., van Duinen N., et al. High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study. Eur J Endocrinol 160 (2009) 357
75. Brown P., Preece M., Brandel J.P., et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55 (2000) 1075